• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BCEL

BCEL

Atreca, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.09

-0.00 (-1.32%)

Company Profile

CEO

John A. Orwin

IPO Date

2019-06-20

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.09

Prev. Close

$0.09

Day Low

$0.09

Day High

$0.09

52W Low

$0.05

52W High

$1.20

Market Cap

$0.00B

Volume

0.12M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

8.3%

Avg Negative

15.6%

Avg Neutral

75.7%

News Feed

Atreca Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

GlobeNewsWire·8/11/2021·↑ positive

BCEL Stock Fell Over 38% Intraday: Why It Happened

Pulse2·7/29/2021·↓ negative

Atreca to Host Webcast Presentation of Initial Clinical Data from Phase 1b Trial of ATRC-101

GlobeNewsWire·7/26/2021·↓ negative

Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors

GlobeNewsWire·7/19/2021·↑ positive

Atreca Reports First Quarter 2021 Financial Results and Recent Corporate Developments

GlobeNewsWire·5/13/2021·↑ positive

Atreca Announces Poster Presentation at the Virtual American Association for Cancer Research (AACR) Annual Meeting

GlobeNewsWire·3/10/2021·↑ positive

Atreca Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments

GlobeNewsWire·2/25/2021·↑ positive

Atreca to Participate at Upcoming Virtual Investor Conferences

GlobeNewsWire·2/22/2021·↑ positive

Atreca to Present at Upcoming Virtual Investor Conferences

GlobeNewsWire·11/6/2020·↑ positive

NSW government wins battle to freeze pay of public servants for 12 months during pandemic

theguardian·10/1/2020·↓ negative